FI962932A0 - Ankkuriproteiinifunktion modulaattoreita - Google Patents

Ankkuriproteiinifunktion modulaattoreita

Info

Publication number
FI962932A0
FI962932A0 FI962932A FI962932A FI962932A0 FI 962932 A0 FI962932 A0 FI 962932A0 FI 962932 A FI962932 A FI 962932A FI 962932 A FI962932 A FI 962932A FI 962932 A0 FI962932 A0 FI 962932A0
Authority
FI
Finland
Prior art keywords
modulators
protein function
anchor protein
anchor
function
Prior art date
Application number
FI962932A
Other languages
English (en)
Swedish (sv)
Other versions
FI962932A (fi
Inventor
Robert Owen Lockerbie
Vincent M Coghlan
Monique L Howard
William M Gallatin
John D Scott
Original Assignee
Icos Corp
Oregon State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/344,227 external-priority patent/US5807693A/en
Application filed by Icos Corp, Oregon State filed Critical Icos Corp
Publication of FI962932A0 publication Critical patent/FI962932A0/fi
Publication of FI962932A publication Critical patent/FI962932A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Bipolar Transistors (AREA)
FI962932A 1994-11-23 1996-07-22 Ankkuriproteiinifunktion modulaattoreita FI962932A (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/344,227 US5807693A (en) 1994-11-23 1994-11-23 Calcineurin inhibitory compounds and anchoring protein
US08/404,731 US5744354A (en) 1994-11-23 1995-03-15 Calcineurin inhibitory compounds and anchoring protein to induce IL-2 gene expression
US08/503,226 US5871945A (en) 1994-11-23 1995-07-17 Modulators of anchoring protein function
PCT/US1995/016039 WO1996016172A2 (en) 1994-11-23 1995-11-22 Modulators of anchoring protein function

Publications (2)

Publication Number Publication Date
FI962932A0 true FI962932A0 (fi) 1996-07-22
FI962932A FI962932A (fi) 1996-09-20

Family

ID=27407605

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962932A FI962932A (fi) 1994-11-23 1996-07-22 Ankkuriproteiinifunktion modulaattoreita

Country Status (14)

Country Link
US (2) US5871945A (fi)
EP (1) EP0748379A1 (fi)
JP (1) JPH09509849A (fi)
CN (1) CN1153830C (fi)
AU (1) AU712168B2 (fi)
BR (1) BR9506540A (fi)
CA (1) CA2181826A1 (fi)
CZ (1) CZ213696A3 (fi)
FI (1) FI962932A (fi)
HU (1) HU221881B1 (fi)
NO (1) NO963049L (fi)
PL (1) PL184659B1 (fi)
SK (1) SK284105B6 (fi)
WO (1) WO1996016172A2 (fi)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998022122A1 (en) * 1996-11-21 1998-05-28 Promega Corporation Alkyl peptide amides and applications
EP0976823A1 (de) * 1998-07-22 2000-02-02 Helge Dr. Völkel Rekombinantes Expressions System und Hoch-Durchsatz BioAssay für die therapeutische Anwendung von Calcineurin-A-Alpha, Calcineurin-A-Beta, Calcineurin-A-Gamma, Calcineurin-B und Copper/Zinc-Superoxide Dismutase bzw. zur Identifizierung von Pharmazeutika
US7109317B1 (en) 1998-11-06 2006-09-19 President And Fellows Of Harvard College FK506-based regulation of biological events
JP2002529081A (ja) * 1998-11-06 2002-09-10 プレジデント アンド フェローズ オブ ハーバード カレッジ 生物学的事象のｆｋ５０６に基づく調節
US7550143B2 (en) 2005-04-06 2009-06-23 Ibc Pharmaceuticals, Inc. Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
US7666400B2 (en) 2005-04-06 2010-02-23 Ibc Pharmaceuticals, Inc. PEGylation by the dock and lock (DNL) technique
US7332275B2 (en) * 1999-10-13 2008-02-19 Sequenom, Inc. Methods for detecting methylated nucleotides
EP1281756A1 (en) * 2001-07-31 2003-02-05 GENOPIA Biomedical GmbH Regulator of calcineurin
EP1501863A4 (en) * 2002-05-03 2007-01-24 Sequenom Inc KINASE ANCHOR PROTEIN, PEPTIDES AND RELATED METHODS THEREOF
US7906118B2 (en) 2005-04-06 2011-03-15 Ibc Pharmaceuticals, Inc. Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology
JP3767632B2 (ja) 2003-05-29 2006-04-19 アステラス製薬株式会社 イヌｃｙｐ１ａ２遺伝子多型
WO2005076886A2 (en) * 2004-02-05 2005-08-25 Irm Llc Prostasin substrates and inhibitors
US8034352B2 (en) 2005-04-06 2011-10-11 Ibc Pharmaceuticals, Inc. Tetrameric cytokines with improved biological activity
US8491914B2 (en) 2004-02-13 2013-07-23 Ibc Pharmaceuticals, Inc. Dock-and-lock (DNL) complexes for delivery of interference RNA
WO2006107617A2 (en) 2005-04-06 2006-10-12 Ibc Pharmaceuticals, Inc. Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
US8349332B2 (en) 2005-04-06 2013-01-08 Ibc Pharmaceuticals, Inc. Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases
US9931413B2 (en) 2005-04-06 2018-04-03 Ibc Pharmaceuticals, Inc. Tetrameric cytokines with improved biological activity
US8481041B2 (en) 2005-04-06 2013-07-09 Ibc Pharmaceuticals, Inc. Dock-and-lock (DNL) constructs for human immunodeficiency virus (HIV) therapy
US9623115B2 (en) 2005-04-06 2017-04-18 Ibc Pharmaceuticals, Inc. Dock-and-Lock (DNL) Complexes for Disease Therapy
US20080242599A1 (en) * 2005-05-03 2008-10-02 Majd Zayzafoon Compositions and Methods for Increasing Osteoblast Cell Differentiation and Bone Generation
US9862770B2 (en) * 2005-10-19 2018-01-09 Ibc Pharmaceuticals, Inc. Multivalent antibody complexes targeting IGF-1R show potent toxicity against solid tumors
CA2734265C (en) 2008-08-20 2017-12-19 Ibc Pharmaceuticals, Inc. Dock-and-lock (dnl) vaccines for cancer therapy
GB201208775D0 (en) 2012-05-18 2012-07-04 Uni I Oslo Chemical compounds
CA2874541A1 (en) 2012-06-01 2013-12-05 Ibc Pharmaceuticals, Inc. Multimeric complexes with improved in vivo stability, pharmacokinetics and efficacy
US9382329B2 (en) 2012-08-14 2016-07-05 Ibc Pharmaceuticals, Inc. Disease therapy by inducing immune response to Trop-2 expressing cells
AU2013302696B9 (en) 2012-08-14 2018-08-09 Ibc Pharmaceuticals, Inc. T-cell redirecting bispecific antibodies for treatment of disease
US20150231241A1 (en) 2012-08-14 2015-08-20 Ibc Pharmaceuticals, Inc. Combination therapy for inducing immune response to disease
US9682143B2 (en) 2012-08-14 2017-06-20 Ibc Pharmaceuticals, Inc. Combination therapy for inducing immune response to disease
EP3062818B1 (en) 2013-11-01 2019-09-11 IBC Pharmaceuticals, Inc. Bispecific antibodies that neutralize both tnf-alpha and il-6: novel therapeutic agent for autoimmune disease
GB201320506D0 (en) 2013-11-26 2014-01-01 Uni I Oslo Cyclic amino compounds for the use in the treatment of cardiac disorders
CN107828815A (zh) * 2017-10-09 2018-03-23 中国农业科学院烟草研究所 一种用于批量转化的酿酒酵母转化方法及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140753A (en) * 1976-04-30 1979-02-20 Scripps Clinic & Research Foundation Diagnostic method and reagent
US4568649A (en) * 1983-02-22 1986-02-04 Immunex Corporation Immediate ligand detection assay
US5169637A (en) * 1983-03-24 1992-12-08 The Liposome Company, Inc. Stable plurilamellar vesicles
US4766046A (en) * 1985-09-27 1988-08-23 Liposome Technology, Inc. Stabilized liposome/amphotericin composition and method
US5180713A (en) * 1985-09-27 1993-01-19 Liposome Technology, Inc. Stabilized liposome/amphotercin B composition and method
US5252263A (en) * 1986-06-16 1993-10-12 The Liposome Company, Inc. Induction of asymmetry in vesicles
US5204112A (en) * 1986-06-16 1993-04-20 The Liposome Company, Inc. Induction of asymmetry in vesicles
US5185154A (en) * 1989-02-02 1993-02-09 Liposome Technology, Inc. Method for instant preparation of a drug containing large unilamellar vesicles
US5283173A (en) * 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
US6080540A (en) * 1990-04-20 2000-06-27 Cold Spring Harbor Laboratory Cloning of mammalian genes in microbial organisms and methods for pharmacological screening
US5158869A (en) * 1990-07-06 1992-10-27 Sangstat Medical Corporation Analyte determination using comparison of juxtaposed competitive and non-competitive elisa results and device therefore
CA2087965A1 (en) * 1990-07-30 1992-02-01 Ajoy Chakrabarti Accumulation of amino acids and peptides into liposomes
US5362629A (en) * 1991-08-05 1994-11-08 President And Fellows Of Harvard College Detection of immunosuppressants
US5807693A (en) * 1994-11-23 1998-09-15 Icos Corporation Calcineurin inhibitory compounds and anchoring protein

Also Published As

Publication number Publication date
NO963049L (no) 1996-09-23
US5871945A (en) 1999-02-16
NO963049D0 (no) 1996-07-22
CA2181826A1 (en) 1996-05-30
CN1153830C (zh) 2004-06-16
JPH09509849A (ja) 1997-10-07
CN1148407A (zh) 1997-04-23
FI962932A (fi) 1996-09-20
EP0748379A1 (en) 1996-12-18
WO1996016172A3 (en) 1996-08-29
BR9506540A (pt) 1997-10-07
HU9602311D0 (en) 1996-10-28
PL315627A1 (en) 1996-11-25
HUT75826A (en) 1997-05-28
HU221881B1 (hu) 2003-02-28
AU712168B2 (en) 1999-10-28
US6107104A (en) 2000-08-22
MX9602798A (es) 1997-12-31
SK95096A3 (en) 1997-07-09
SK284105B6 (sk) 2004-09-08
CZ213696A3 (en) 1997-05-14
WO1996016172A2 (en) 1996-05-30
PL184659B1 (pl) 2002-11-29
AU4513396A (en) 1996-06-17

Similar Documents

Publication Publication Date Title
FI962932A (fi) Ankkuriproteiinifunktion modulaattoreita
NO993068D0 (no) Ny forbindelsesform
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
DE69725205D1 (de) Befestigung von Biomolekülen
DE69718393T2 (de) Befestigung von Biomolekülen
DE69631056D1 (de) Zusammensetzungen von süssigkeiten
DE69601322D1 (de) Verankerungselement
DE69634998D1 (de) Kontrolle von Kanten
DE69626729D1 (de) Kombination von Datenwerten
NO983632L (no) Krystallform av N-(4-trifluormetylfenyl)-5-metyl-isoksazol-4-karboksamid
DE69628195D1 (de) Verwendung von xyloglucanendotransglycosylase
DE59607408D1 (de) Mischungen von Monoazopyridonfarbstoffen
NO991148D0 (no) Fremstilling av 1-butyl-4-piperidinyl-metylamin
DE69603565D1 (de) Isomerisierung von Equilin
NO962414D0 (no) Anker
NO954190L (no) Anker
DE29622383U1 (de) Verbindungsanordnung von Bauelementen
DE69804782D1 (de) Isomerisierung von fluorkohlenwasserstoffen
DE69713192D1 (de) Kombination von Enzymen
KR960029215U (ko) 스트롱 앵커
DE59611096D1 (de) Funktionalität von endgeräten
DE9421742U1 (de) Kontaktierung von Betätigungs- und Anzeigemitteln
NO994977D0 (no) Fremstilling av enantiomerfrie biarylketokarboksylsyrer
KR970011853U (ko) 새로운 형태의 메리야스
DE29508755U1 (de) Abdichtung von zusammengefügten Bauteilen

Legal Events

Date Code Title Description
MA Patent expired